Ceftriaxone Supplier-Buyer Network — Trade Flow Analysis

Name: Ceftriaxone Supplier-Buyer Trade Network Dataset — 850+ Indian Exporters, 24+ Importers, 162+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Ceftriaxone supplier network, Ceftriaxone buyers, pharmaceutical export India, Ceftriaxone trade data

TransData Nexus

Ceftriaxone

India Pharmaceutical Trade Intelligence

$285.4M850 Suppliers162 CountriesHS 30042019

ExportsIndia → KENYA17.7%India → AFGHANISTAN7.3%

ImportsIRAQ → India$50.2K UNITED ARAB → India$41.4K

#1 Supplier: INNOVA CAPTAB #1 Buyer: ROYAL PHARMA

Who Supplies Ceftriaxone? Top Manufacturers & Buyers 2026 — INNOVA CAPTAB LIMITED Leads | TransData Nexus | TransData Nexus

1INNOVA CAPTAB LIMITED

INNOVA CAPTAB LIMITED is the first-largest Ceftriaxone exporter from India, with a market share of 11.2% and a total export value of $31.9M across 600 shipments. Their average shipment value of $53.2K is above the market average of $25.4K, suggesting premium or bulk contract pricing.

INNOVA CAPTAB LIMITED serves 5 named buyers in our database. ROYAL PHARMA 2011 LIMITED is the dominant customer, accounting for 92.0% of this supplier's tracked business. Top customers include:

• ROYAL PHARMA 2011 LIMITED — $29.3M across 552 shipments (92.0% of this supplier's total exports)

• ELWALIEF INTERNATION — $955.6K across 18 shipments (3.0% of this supplier's total exports)

• ROYAL PHARMA 2011 LIMITED — $594.3K across 11 shipments (1.9% of this supplier's total exports)

• TO THE ORDER OF — $548.3K across 10 shipments (1.7% of this supplier's total exports)

• CROWN SOLUTIONS LTD — $465.6K across 9 shipments (1.5% of this supplier's total exports)

Key Insight: INNOVA CAPTAB LIMITED's per-shipment value of $53.2K is 110% above the market average of $25.4K, consistent with large-order contracts or value-added formulations.

2UNIVENTIS MEDICARE LIMITED

UNIVENTIS MEDICARE LIMITED is the second-largest Ceftriaxone exporter from India, with a market share of 5.3% and a total export value of $15.1M across 111 shipments. Their average shipment value of $136.0K is above the market average of $25.4K, suggesting premium or bulk contract pricing.

UNIVENTIS MEDICARE LIMITED serves 4 named buyers in our database. SAAM GROUP LTD is the dominant customer, accounting for 97.5% of this supplier's tracked business. Top customers include:

• SAAM GROUP LTD — $14.7M across 108 shipments (97.5% of this supplier's total exports)

• SHAMS NOORI PHARMA T — $207.1K across 2 shipments (1.4% of this supplier's total exports)

• SAAM GROUP LIMITED — $128.5K across 1 shipments (0.9% of this supplier's total exports)

• SHAMS NOORI PHARMA T — $41.1K across 0 shipments (0.3% of this supplier's total exports)

Key Insight: UNIVENTIS MEDICARE LIMITED's per-shipment value of $136.0K is 436% above the market average of $25.4K, consistent with large-order contracts or value-added formulations.

3UNILINK PHARMA PRIVATE LIMITED

UNILINK PHARMA PRIVATE LIMITED is the third-largest Ceftriaxone exporter from India, with a market share of 4.8% and a total export value of $13.7M across 26 shipments. Their average shipment value of $526.3K is above the market average of $25.4K, suggesting premium or bulk contract pricing.

UNILINK PHARMA PRIVATE LIMITED serves 4 named buyers in our database. PHARMACIE CENTRALE GUINEE is the dominant customer, accounting for 98.8% of this supplier's tracked business. Top customers include:

• PHARMACIE CENTRALE GUINEE — $13.5M across 26 shipments (98.8% of this supplier's total exports)

• SOGUIMAP SARL — $116.8K across 0 shipments (0.9% of this supplier's total exports)

• GUIBIOMED — $36.4K across 0 shipments (0.3% of this supplier's total exports)

• AFRIMED SARL — $14.2K across 0 shipments (0.1% of this supplier's total exports)

Key Insight: UNILINK PHARMA PRIVATE LIMITED's per-shipment value of $526.3K is 1975% above the market average of $25.4K, consistent with large-order contracts or value-added formulations.

4MEDCELL PHARMA

MEDCELL PHARMA is the fourth-largest Ceftriaxone exporter from India, with a market share of 3.6% and a total export value of $10.3M across 54 shipments. Their average shipment value of $190.4K is above the market average of $25.4K, suggesting premium or bulk contract pricing.

MEDCELL PHARMA serves 5 named buyers in our database. SEA GOLD PHARMA is the dominant customer, accounting for 98.0% of this supplier's tracked business. Top customers include:

• SEA GOLD PHARMA — $10.1M across 53 shipments (98.0% of this supplier's total exports)

• FAQIR ZAMAN LTD — $69.4K across 0 shipments (0.7% of this supplier's total exports)

• MILAD MUSAWAR TRADE — $47.5K across 0 shipments (0.5% of this supplier's total exports)

• EXONIC SHIPPING LLC( — $45.3K across 0 shipments (0.4% of this supplier's total exports)

• V.I.P SHIPPING (L.L. — $45.3K across 0 shipments (0.4% of this supplier's total exports)

Key Insight: MEDCELL PHARMA's per-shipment value of $190.4K is 651% above the market average of $25.4K, consistent with large-order contracts or value-added formulations.

5LINCOLN PHARMACEUTICALS LTD

LINCOLN PHARMACEUTICALS LTD is the fifth-largest Ceftriaxone exporter from India, with a market share of 3.0% and a total export value of $8.6M across 54 shipments. Their average shipment value of $159.6K is above the market average of $25.4K, suggesting premium or bulk contract pricing.

LINCOLN PHARMACEUTICALS LTD serves 5 named buyers in our database. KHAN SEHAT LTD is the dominant customer, accounting for 94.3% of this supplier's tracked business. Top customers include:

• KHAN SEHAT LTD — $8.1M across 51 shipments (94.3% of this supplier's total exports)

• UNIQUE PHARMA — $331.8K across 2 shipments (3.9% of this supplier's total exports)

• UNIQUE PHARMA STE UN — $114.5K across 1 shipments (1.3% of this supplier's total exports)

• PLANET PHARMA — $26.9K across 0 shipments (0.3% of this supplier's total exports)

• K S L — $16.1K across 0 shipments (0.2% of this supplier's total exports)

Key Insight: LINCOLN PHARMACEUTICALS LTD's per-shipment value of $159.6K is 529% above the market average of $25.4K, consistent with large-order contracts or value-added formulations.

6AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD is the fifth-largest Ceftriaxone exporter from India, with a market share of 1.1% and a total export value of $3.0M across 184 shipments. Their average shipment value of $16.4K is below the market average of $25.4K, reflecting a high-volume, competitive pricing strategy.

AUROBINDO PHARMA LTD serves 4 named buyers in our database. EUGIA PHARMA INDUSTRIA FARMACEUTICA is the dominant customer, accounting for 62.2% of this supplier's tracked business. Top customers include:

• EUGIA PHARMA INDUSTRIA FARMACEUTICA — $1.9M across 114 shipments (62.2% of this supplier's total exports)

• AUROVIDA FARMACEUTICA, SA DE CV, — $1.1M across 68 shipments (37.1% of this supplier's total exports)

• GENERICS & SPECIALIT — $19.3K across 1 shipments (0.6% of this supplier's total exports)

• SIMBA PHARMACEUTICAL — $3.3K across 0 shipments (0.1% of this supplier's total exports)

Key Insight: AUROBINDO PHARMA LTD operates with high shipment frequency (184 shipments) at a per-shipment value of $16.4K, indicating a broad distribution network with many smaller, regular orders.

1Kenya

Kenya ranks as the first-largest destination for Ceftriaxone imports from India, with a total trade value of $50.6M across 135 shipments — representing a 17.7% share of all Ceftriaxone exports. The average shipment value of $374.5K is above the global average of $25.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Ceftriaxone importers in Kenya: ROYAL PHARMA 2011 LIMITED is the largest buyer, accounting for 59.0% ($29.8M) of this market's total imports.

• ROYAL PHARMA 2011 LIMITED — $29.8M (59.0% of Kenya's total)

Key Insight: Kenya's per-shipment average of $374.5K (1377% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Kenya is a key market for Ceftriaxone imports from India.

Primary Market

Secondary Market

2Afghanistan

Afghanistan ranks as the second-largest destination for Ceftriaxone imports from India, with a total trade value of $20.9M across 15 shipments — representing a 7.3% share of all Ceftriaxone exports. The average shipment value of $1.4M is above the global average of $25.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Ceftriaxone importers in Afghanistan: KHAN SEHAT LTD is the largest buyer, accounting for 39.4% ($8.2M) of this market's total imports.

• KHAN SEHAT LTD — $8.2M (39.4% of Afghanistan's total)

Key Insight: Afghanistan's per-shipment average of $1.4M (5387% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Afghanistan is a key market for Ceftriaxone imports from India.

Primary Market

Secondary Market

3Mexico

Mexico ranks as the third-largest destination for Ceftriaxone imports from India, with a total trade value of $16.7M across 108 shipments — representing a 5.9% share of all Ceftriaxone exports. The average shipment value of $155.0K is above the global average of $25.4K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Ceftriaxone importers in Mexico: AUROVIDA FARMACEUTICA, SA DE CV, is the largest buyer, accounting for 52.0% ($8.7M) of this market's total imports.

• AUROVIDA FARMACEUTICA, SA DE CV, — $8.7M (52.0% of Mexico's total)

• PRODUCTOS FARMACEUTICOS COLLINS, — $2.0M (11.7% of Mexico's total)

Key Insight: Mexico's per-shipment average of $155.0K (511% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Mexico is a key market for Ceftriaxone imports from India.

Primary Market

Secondary Market

4Guinea

Guinea ranks as the fourth-largest destination for Ceftriaxone imports from India, with a total trade value of $14.1M across 3 shipments — representing a 5.0% share of all Ceftriaxone exports. The average shipment value of $4.7M is above the global average of $25.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Ceftriaxone importers in Guinea: PHARMACIE CENTRALE GUINEE is the largest buyer, accounting for 96.2% ($13.6M) of this market's total imports.

• PHARMACIE CENTRALE GUINEE — $13.6M (96.2% of Guinea's total)

Key Insight: Guinea's per-shipment average of $4.7M (18482% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Guinea is a key market for Ceftriaxone imports from India.

Primary Market

Secondary Market

5Ethiopia

Ethiopia ranks as the fifth-largest destination for Ceftriaxone imports from India, with a total trade value of $13.2M across 0 shipments — representing a 4.6% share of all Ceftriaxone exports. The average shipment value of $13.2M is above the global average of $25.4K, indicating high-value procurement contracts or branded formulations.

Key Insight: Ethiopia's per-shipment average of $13.2M (52146% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Ethiopia is a key market for Ceftriaxone imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Ceftriaxone.
2.Flow Mapping: 850 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 11,257 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 162 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

11,257 Verified Shipments

850 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Ceftriaxone

Ceftriaxone

Who Supplies Ceftriaxone? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Ceftriaxone — Export Intelligence Video

Market Intelligence

Official References & Regulatory Resources

Who Supplies Ceftriaxone? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Ceftriaxone Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1INNOVA CAPTAB LIMITED

2UNIVENTIS MEDICARE LIMITED

3UNILINK PHARMA PRIVATE LIMITED

4MEDCELL PHARMA

5LINCOLN PHARMACEUTICALS LTD

6AUROBINDO PHARMA LTD

From Indian Factories to Global Pharmacies — How Ceftriaxone Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Ceftriaxone Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Kenya

2Afghanistan

3Mexico

4Guinea

5Ethiopia

People Also Ask — Ceftriaxone Supplier & Trade Network

Ceftriaxone Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology